Cm Management, LLC Compass Therapeutics, Inc. Transaction History
Cm Management, LLC
- $115 Million
- Q1 2024
A detailed history of Cm Management, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 310,000 shares of CMPX stock, worth $254,199. This represents 0.53% of its overall portfolio holdings.
Number of Shares
310,000
Previous 125,000
148.0%
Holding current value
$254,199
Previous $195,000
214.36%
% of portfolio
0.53%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$18.3 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$9.13 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$5.32 Million0.01% of portfolio
-
Blackstone Inc New York, NY6.19MShares$5.08 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$4.95 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $83.1M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...